Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aduhelm
Biotech
Dunn with the FDA: Head of agency's neuroscience unit to depart
Bill Dunn is leaving his post atop the FDA's neuroscience office to pursue new opportunities, according to an email sent to staff.
Max Bayer
Feb 27, 2023 12:32pm
Accelerated approval reforms land in Congress' spending bill
Dec 20, 2022 11:31am
Winner crowned in Alzheimer's contest between Aduhelm and Lilly
Dec 1, 2022 5:30am
Eisai makes the case for lecanemab after 2nd patient death
Nov 29, 2022 7:50pm
J&J's Janssen aims for 'sweet spot' of Alzheimer's R&D
Aug 1, 2022 8:00am
Roche, Biogen temper Alzheimer's expectations in Q2 calls
Jul 22, 2022 9:07am
